Glucose metabolism in burn patients: The role of insulin and other endocrine hormones

Burns

Volumn 36, Issue 5, 2010, Pages 599-605

  Ballian, Nikiforos ^a   Rabiee, Atoosa ^b   Andersen, Dana K ^b   Elahi, Dariush ^b   Gibson, B Robert ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Burn ICU; GLP 1; Glycemic control; Insulin

Indexed keywords

AMINO ACID; CATECHOLAMINE; CORTICOSTEROID; FENOFIBRATE; GLUCAGON; GLUCOSE; GROWTH HORMONE; INSULIN; INTERLEUKIN 6; METFORMIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MUSCLE PROTEIN; OXANDROLONE; PENTOSE PHOSPHATE; SOMATOMEDIN; TUMOR NECROSIS FACTOR;

BIOSYNTHESIS; BLOOD CLOTTING DISORDER; BLOOD GLUCOSE MONITORING; BURN PATIENT; CATABOLISM; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; ENERGY EXPENDITURE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFECTION CONTROL; INFLAMMATION; INJURY SEVERITY; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TREATMENT; LEUKOPENIA; LIPOGENESIS; MORBIDITY; MORTALITY; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PENTOSE PHOSPHATE CYCLE; PROTEIN DEGRADATION; PROTEIN METABOLISM; RENAL REPLACEMENT THERAPY; REVIEW; SKELETAL MUSCLE; SURGICAL PATIENT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THERMAL INJURY; WOUND; WOUND HEALING;

BLOOD GLUCOSE; BURNS; GLUCONEOGENESIS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; METFORMIN;

EID: 77953121747     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2009.11.008     Document Type: Review

References (73)

1. Ipaktchi K., and Arbabi S. Advances in burn critical care. Crit Care Med 34 9 Suppl. (2006) S239-S244
2. Gauglitz G.G., Herndon D.N., Kulp G.A., Meyer III W.J., and Jeschke M.G. Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab 94 5 (2009) 1656-1664
3. Gore D.C., and Jahoor F. Glutamine kinetics in burn patients. Comparison with hormonally induced stress in volunteers. Arch Surg 129 12 (1994) 1318-1323
4. Gore D.C., Chinkes D.L., Wolf S.E., Sanford A.P., Herndon D.N., and Wolfe R.R. Quantification of protein metabolism in vivo for skin, wound, and muscle in severe burn patients. JPEN 30 4 (2006) 331-338
5. Gore D.C., Wolf S.E., Herndon D.N., and Wolfe R.R. Relative influence of glucose and insulin on peripheral amino acid metabolism in severely burned patients. JPEN 26 5 (2002) 271-277
6. Ferrando A.A., Chinkes D.L., Wolf S.E., Matin S., Herndon D.N., and Wolfe R.R. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg 229 1 (1999) 11-18
7. Sakurai Y., Aarsland A., Herndon D.N., Chinkes D.L., Pierre E., Nguyen T.T., et al. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg 222 3 (1995) 283-94; 94-7
8. Jahoor F., Herndon D.N., and Wolfe R.R. Role of insulin and glucagon in the response of glucose and alanine kinetics in burn-injured patients. J Clin Invest 78 3 (1986) 807-814
9. Gore D.C., Chinkes D.L., Hart D.W., Wolf S.E., Herndon D.N., and Sanford A.P. Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med 30 11 (2002) 2438-2442
10. Vanhorebeek I., Ellger B., De Vos R., Boussemaere M., Debaveye Y., Perre S.V., et al. Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness. Crit Care Med 37 4 (2009) 1355-1364
11. Wolfe R.R., Jahoor F., Herndon D.N., and Miyoshi H. Isotopic evaluation of the metabolism of pyruvate and related substrates in normal adult volunteers and severely burned children: effect of dichloroacetate and glucose infusion. Surgery 110 1 (1991) 54-67
12. Yu Y.M., Tompkins R.G., Ryan C.M., and Young V.R. The metabolic basis of the increase of the increase in energy expenditure in severely burned patients. JPEN 23 3 (1999) 160-168
13. Yarmush D.M., MacDonald A.D., Foy B.D., Berthiaume F., Tompkins R.G., and Yarmush M.L. Cutaneous burn injury alters relative tricarboxylic acid cycle fluxes in rat liver. J Burn Care Rehabil 20 4 (1999) 292-302
14. Burke J.F., Wolfe R.R., Mullany C.J., Mathews D.E., and Bier D.M. Glucose requirements following burn injury. Parameters of optimal glucose infusion and possible hepatic and respiratory abnormalities following excessive glucose intake. Ann Surg 190 3 (1979) 274-285
15. Wolfe R.R., Durkot M.J., Allsop J.R., and Burke J.F. Glucose metabolism in severely burned patients. Metabolism 28 10 (1979) 1031-1039
16. Wolfe R.R. Metabolic response to burn injury: nutritional implications. Keio J Med 42 1 (1993) 1-8
17. Jahoor F., Shangraw R.E., Miyoshi H., Wallfish H., Herndon D.N., and Wolfe R.R. Role of insulin and glucose oxidation in mediating the protein catabolism of burns and sepsis. Am J Physiol 257 3 Pt 1 (1989) E323-E331
18. Yamaguchi Y., Yu Y.M., Zupke C., Yarmush D.M., Berthiaume F., Tompkins R.G., et al. Effect of burn injury on glucose and nitrogen metabolism in the liver: preliminary studies in a perfused liver system. Surgery 121 3 (1997) 295-303
19. Durkot M.J., and Wolfe R.R. Effects of adrenergic blockade on glucose kinetics in septic and burned guinea pigs. Am J Physiol 241 3 (1981) R222-R227
20. Wolfe R.R., Herndon D.N., Jahoor F., Miyoshi H., and Wolfe M. Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med 317 7 (1987) 403-408
21. Lee K., Berthiaume F., Stephanopoulos G.N., Yarmush D.M., and Yarmush M.L. Metabolic flux analysis of postburn hepatic hypermetabolism. Metab Eng 2 4 (2000) 312-327
22. Cree M.G., and Wolfe R.R. Postburn trauma insulin resistance and fat metabolism. Am J Physiol Endocrinol Metab 294 1 (2008) E1-E9
23. Gauglitz G.G., Herndon D.N., and Jeschke M.G. Insulin resistance postburn: underlying mechanisms and current therapeutic strategies. J Burn Care Res 29 5 (2008) 683-694
24. Carter E.A., Tompkins R.G., Babich J.W., Correia J., Bailey E.M., and Fischman A.J. Thermal injury in rats alters glucose utilization by skin, wound, and small intestine, but not by skeletal muscle. Metabolism 45 9 (1996) 1161-1167
25. DeFronzo R. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia 21 (1981) 165-171
26. Fang C.H., Li B.G., James J.H., Fischer J.E., and Hasselgren P.O. Cytokines block the effects of insulin-like growth factor-I (IGF-I) on glucose uptake and lactate production in skeletal muscle but do not influence IGF-I-induced changes in protein turnover. Shock 8 5 (1997) 362-367
27. Pidcoke H.F., Salinas J., Wanek S.M., Concannon M., Loo F., Wirfel K.L., et al. Patterns of exogenous insulin requirement reflect insulin sensitivity changes in trauma. Am J Surg 194 6 (2007) 798-803 [discussion]
28. Sugita H., Kaneki M., Sugita M., Yasukawa T., Yasuhara S., and Martyn J.A. Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle. Am J Physiol Endocrinol Metab 288 3 (2005) E585-E591
29. Gore D.C., Wolf S.E., Sanford A.P., Herndon D.N., and Wolfe R.R. Extremity hyperinsulinemia stimulates muscle protein synthesis in severely injured patients. Am J Physiol Endocrinol Metab 286 4 (2004) E529-E534
30. Zhang X.J., Chinkes D.L., Irtun O., and Wolfe R.R. Anabolic action of insulin on skin wound protein is augmented by exogenous amino acids. Am J Physiol Endocrinol Metab 282 6 (2002) E1308-E1315
31. Gore D.C., Chinkes D., Heggers J., Herndon D.N., Wolf S.E., and Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 51 3 (2001) 540-544
32. Clement S., Braithwaite S.S., Magee M.F., Ahmann A., Smith E.P., Schafer R.G., et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 27 2 (2004) 553-591
33. Black C.T., Hennessey P.J., and Andrassy R.J. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. J Trauma 30 7 (1990) 830-832 [discussion 2-3]
34. von Kanel R., Mills P.J., and Dimsdale J.E. Short-term hyperglycemia induces lymphopenia and lymphocyte subset redistribution. Life Sci 69 3 (2001) 255-262
35. Perner A., Nielsen S.E., and Rask-Madsen J. High glucose impairs superoxide production from isolated blood neutrophils. Intens Care Med 29 4 (2003) 642-645
36. Mowlavi A., Andrews K., Milner S., Herndon D.N., and Heggers J.P. The effects of hyperglycemia on skin graft survival in the burn patient. Ann Plast Surg 45 6 (2000) 629-632
37. Weekers F., Giulietti A.P., Michalaki M., Coopmans W., Van Herck E., Mathieu C., et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 144 12 (2003) 5329-5338
38. Langouche L., Vanhorebeek I., Vlasselaers D., Vander Perre S., Wouters P.J., Skogstrand K., et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 115 8 (2005) 2277-2286
39. Padfield K.E., Astrakas L.G., Zhang Q., Gopalan S., Dai G., Mindrinos M.N., et al. Burn injury causes mitochondrial dysfunction in skeletal muscle. Proc Natl Acad Sci USA 102 15 (2005) 5368-5373
40. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 9206 (2000) 773-778
41. Capes S.E., Hunt D., Malmberg K., Pathak P., and Gerstein H.C. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32 10 (2001) 2426-2432
42. Srinivasan V., Spinella P.C., Drott H.R., Roth C.L., Helfaer M.A., and Nadkarni V. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med 5 4 (2004) 329-336
43. Gore D.C., Wolf S.E., Herndon D.N., and Wolfe R.R. Metformin blunts stress-induced hyperglycemia after thermal injury. J Trauma 54 3 (2003) 555-561
44. Arora N.S., and Rochester D.F. Respiratory muscle strength and maximal voluntary ventilation in undernourished patients. Am Rev Respir Dis 126 1 (1982) 5-8
45. Biolo G., Declan Fleming R.Y., and Wolfe R.R. Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle. J Clin Invest 95 2 (1995) 811-819
46. Thomas S.J., Morimoto K., Herndon D.N., Ferrando A.A., Wolfe R.R., Klein G.L., et al. The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery 132 2 (2002) 341-347
47. Van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 19 (2001) 1359-1367
48. Holm C., Horbrand F., Mayr M., von Donnersmarck G.H., and Muhlbauer W. Acute hyperglycaemia following thermal injury: friend or foe?. Resuscitation 60 1 (2004) 71-77
49. Ellger B., Debaveye Y., Vanhorebeek I., Langouche L., Giulietti A., Van Etten E., et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 55 4 (2006) 1096-1105
50. Van den Berghe G., Wouters P.J., Bouillon R., Weekers F., Verwaest C., Schetz M., et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31 2 (2003) 359-366
51. Jeschke M.G., Einspanier R., Klein D., and Jauch K.W. Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med 8 8 (2002) 443-450
52. Jeschke M.G., Klein D., and Herndon D.N. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 239 4 (2004) 553-560
53. Wu X., Thomas S.J., Herndon D.N., Sanford A.P., and Wolf S.E. Insulin decreases hepatic acute phase protein levels in severely burned children. Surgery 135 2 (2004) 196-202
54. Jeschke M.G., Barrow R.E., and Herndon D.N. Extended hypermetabolic response of the liver in severely burned pediatric patients. Arch Surg 139 6 (2004) 641-647
55. Jeschke M.G., Rensing H., Klein D., Schubert T., Mautes A.E., Bolder U., et al. Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J Hepatol 42 6 (2005) 870-879
56. Klein D., Schubert T., Horch R.E., Jauch K.W., and Jeschke M.G. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann Surg 240 2 (2004) 340-349
57. Cochran A., Davis L., Morris S.E., and Saffle J.R. Safety and efficacy of an intensive insulin protocol in a burn-trauma intensive care unit. J Burn Care Res 29 1 (2008) 187-191
58. Pham T.N., Warren A.J., Phan H.H., Molitor F., Greenhalgh D.G., and Palmieri T.L. Impact of tight glycemic control in severely burned children. J Trauma 59 5 (2005) 1148-1154
59. Gibson B.R., Galiatsatos P., Rabiee A., Eaton L., Abu-Hamdah R., Christmas C., et al. Intensive insulin therapy confers a similar survival benefit in the burn intensive care unit as in the surgical intensive care unit. Surgery 146 5 (2009) 922-930
60. Van den Berghe G., Wilmer A., Hermans G., Meersseman W., Wouters P.J., Milants I., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 5 (2006) 449-461
61. Malmberg K.A., Efendic S., and Ryden L.E. Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction. A report from the multicenter trial: DIGAMI. Diabetes Care 17 9 (1994) 1007-1014
62. Goldberg P.A. Memoirs of a root canal salesman: the successful implementation of a hospital-wide intravenous insulin infusion protocol. Endocr Pract 12 Suppl. 3 (2006) 79-85
63. Furnary A.P., Wu Y., and Bookin S.O. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 10 Suppl 2 (2004) 21-33
64. Aarsland A., Chinkes D., and Wolfe R.R. Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. J Clin Invest 98 9 (1996) 2008-2017
65. Gibbons G.F. Insulin, diabetes and hepatic very-low-density lipoprotein metabolism. Biochem Soc Trans 17 1 (1989) 49-51
66. Aarsland A., Chinkes D.L., Sakurai Y., Nguyen T.T., Herndon D.N., and Wolfe R.R. Insulin therapy in burn patients does not contribute to hepatic triglyceride production. J Clin Invest 101 10 (1998) 2233-2239
67. Emanuele N.V., Emanuele M.A., Morgan M.O., Sulo D., Yong S., Kovacs E.J., et al. Ethanol potentiates the acute Fatty infiltration of liver caused by burn injury: prevention by insulin treatment. J Burn Care Res 30 3 (2009) 482-488
68. Shangraw R.E., Jahoor F., Miyoshi H., Neff W.A., Stuart C.A., Herndon D.N., et al. Differentiation between septic and postburn insulin resistance. Metabolism 38 10 (1989) 983-989
69. Stumvoll M., Nurjhan N., Perriello G., Dailey G., and Gerich J.E. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 333 9 (1995) 550-554
70. Cree M.G., Zwetsloot J.J., Herndon D.N., Qian T., Morio B., Fram R., et al. Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate. Ann Surg 245 2 (2007) 214-221
71. Jenkins R.C., and Ross R.J. Growth hormone therapy for protein catabolism. QJM 89 11 (1996) 813-819
72. Tessari P., Trevisan R., Inchiostro S., Biolo G., Nosadini R., De Kreutzenberg S.V., et al. Dose-response curves of effects of insulin on leucine kinetics in humans. Am J Physiol 251 3 Pt 1 (1986) E334-E342
73. Kettelhut I.C., Wing S.S., and Goldberg A.L. Endocrine regulation of protein breakdown in skeletal muscle. Diabetes Metab Rev 4 8 (1988) 751-772